QIAGEN announced a first-in-kind collaboration with Penn State University in the United States to create a shared research and education facility for the f...
Hummingbird Diagnostics GmbH, a leader in the analysis of blood-based small RNA (sRNA) for the early detection and characterization of diseases, today anno...
Embracing the latest technology trends, LPH 1.0 represents a significant leap forward, with an upgrade to HTML5 browser-based technology. This advancement ...
The acquisition is expected to close on February 1, 2024, subject to customary closing conditions. By bringing the Precise Tumor and Precise Liquid tests i...
Agilent Technologies Inc. announced the release of a new automated parallel capillary electrophoresis system for protein analysis – the Agilent ...
MoBiTec will be integrated with BIOZOL Diagnostica GmbH, a subsidiary of Calibre Scientific, enhancing its sales capabilities and product range for custome...
QIAGEN announced a strategic plan to step up investments over the next five years in its market-leading QIAGEN Digital Insights (QDI) business. These inve...
Thrive Bioscience Inc., a provider of innovative automated live cell imaging instruments and software, debuted its CellAssist Software Release 5.0, a new i...
-Agilent Technologies Inc. (NYSE: A) announced the addition of water immersion and new confocal spinning disk technology to the BioTek Cytation C10 c...
Adds to robust offering of NGS tools enabling exome sequencing, whole genome sequencing, RNA sequencing and methylation detection Enables multiplexing and...
American College of Gastroenterology (ACG) gives BLUE-C study late breaker status at 2023 annual meeting with presentation of the only head-to-head study r...
To support emerging precision therapies and improve patient outcomes by increasing access to reliable genomic testing needed to match patients with targete...
Charles River Laboratories International, Inc. announced the ability to conduct preclinical cancer research using ITCC-P4’s well-characterized collec...
QIAGEN announced the launch of its QuantiFERON-EBV RUO (Research Use Only) assay. Epstein-Barr virus (EBV), or human herpes virus 4, is estimated in ...
© 2025 Biopharma Boardroom. All Rights Reserved.
